T1	Post-eligibility 0 83	Unwillingness or inability to comply with the procedures described in this protocol
T2	Temporal 146 169	within the study period
T3	Procedure 138 145	surgery
T4	Qualifier 130 137	cardiac
T5	Negation 126 129	non
R1	Has_negation Arg1:T4 Arg2:T5	
R2	Has_qualifier Arg1:T3 Arg2:T4	
T6	Qualifier 120 125	major
R3	Has_qualifier Arg1:T3 Arg2:T6	
T7	Mood 112 119	planned
R4	Has_mood Arg1:T3 Arg2:T7	
T8	Procedure 93 108	cardiac surgery
T9	Mood 85 92	Planned
R5	Has_mood Arg1:T8 Arg2:T9	
*	OR T8 T3
T10	Scope 85 145	Planned cardiac surgery or planned major non-cardiac surgery
R6	Has_temporal Arg1:T7 Arg2:T2	
T11	Reference_point 157 169	study period
R7	Has_index Arg1:T2 Arg2:T11	
T12	Procedure 182 208	coronary revascularization
T13	Procedure 172 178;191 208	Stroke revascularization
*	OR T12 T13
T14	Temporal 209 229	in the past 6 months
T15	Scope 172 208	Stroke or coronary revascularization
R8	Has_temporal Arg1:T15 Arg2:T14	
T16	Condition 255 272	pulmonary disease
T17	Qualifier 232 242;243 254	Clinically significant
R9	Has_qualifier Arg1:T16 Arg2:T17	
T18	Condition 285 300	hyperthyroidism
T19	Condition 305 319	hypothyroidism
*	OR T18 T19
T20	Qualifier 275 284	Untreated
T21	Scope 285 319	hyperthyroidism, or hypothyroidism
R10	Has_qualifier Arg1:T21 Arg2:T20	
T22	Condition 337 343	cancer
T23	Negation 345 355	other than
T24	Condition 356 376;391 402	superficial squamous skin cancer
T25	Condition 380 402	basal cell skin cancer
*	OR T25 T24
T26	Scope 356 402	superficial squamous or basal cell skin cancer
R11	Has_negation Arg1:T26 Arg2:T23	
T27	Temporal 404 423	in the past 3 years
T28	Procedure 435 444	treatment
T29	Condition 460 466	cancer
T30	Qualifier 453 459	active
R12	Has_qualifier Arg1:T29 Arg2:T30	
R13	AND Arg1:T28 Arg2:T29	
T31	Scope 337 403	cancer (other than superficial squamous or basal cell skin cancer)
R14	Has_temporal Arg1:T31 Arg2:T27	
*	OR T31 T28
T32	Pregnancy_considerations 469 585	Female of child-bearing potential who do not use adequate contraception and women who are pregnant or breast-feeding
T33	Subjective_judgement 587 809	Any clinically significant abnormality identified at the screening visit, physical examination, laboratory tests, or electrocardiogram which, in the judgment of the Investigator, would preclude safe completion of the study
T34	Measurement 812 832	LV ejection fraction
T35	Value 833 838	< 50%
R15	Has_value Arg1:T34 Arg2:T35	
T36	Condition 853 866	renal disease
T37	Qualifier 841 852	Significant
R16	Has_qualifier Arg1:T36 Arg2:T37	
T38	Measurement 881 897	serum creatinine
T39	Value 898 909	> 2.5 mg/dL
R17	Has_value Arg1:T38 Arg2:T39	
R18	AND Arg1:T36 Arg2:T38	
T40	Condition 911 926	Hepatic disease
T41	Condition 930 955	biliary tract obstruction
T42	Condition 972 996	hepatic enzyme elevation
T43	Qualifier 960 971	significant
R19	Has_qualifier Arg1:T42 Arg2:T43	
T44	Measurement 998 1001	ALT
T45	Measurement 1005 1008	AST
T46	Value 1009 1040	> 3 times upper limit of normal
*	OR T44 T45
T47	Scope 998 1008	ALT or AST
R20	Has_value Arg1:T47 Arg2:T46	
R21	Has_scope Arg1:T42 Arg2:T47	
*	OR T40 T41 T42
T48	Condition 1055 1066	intolerance
T49	Drug 1070 1073	ARB
T50	Drug 1077 1087	amlodipine
*	OR T49 T50
T51	Scope 1070 1087	ARB or amlodipine
R22	Has_scope Arg1:T48 Arg2:T51	
T52	Condition 1106 1132	restrictive cardiomyopathy
T53	Condition 1090 1102;1118 1132	Hypertrophic cardiomyopathy
T54	Condition 1154 1170	valvular disease
T55	Qualifier 1147 1153	severe
T56	Qualifier 1135 1143	Moderate
*	OR T56 T55
T57	Scope 1135 1153	Moderate or severe
R23	Has_scope Arg1:T54 Arg2:T57	
T58	Condition 1173 1198	Constrictive pericarditis
T59	Condition 1200 1219	Atrial fibrillation
T60	Measurement 1227 1237	heart rate
T61	Value 1238 1247	> 120/min
R24	Has_value Arg1:T60 Arg2:T61	
R25	AND Arg1:T59 Arg2:T60	
T62	Condition 1258 1269	systolic BP
T63	Qualifier 1250 1257	Sitting
R26	Has_qualifier Arg1:T62 Arg2:T63	
T64	Value 1270 1280	< 100 mmHg
R27	Has_value Arg1:T62 Arg2:T64	
